Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
@article{Mohammad1998SuccessfulTO, title={Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.}, author={R. Mohammad and M. Varterasian and V. P. Almatchy and G. N. Hannoudi and G. Pettit and A. Al-katib}, journal={Clinical cancer research : an official journal of the American Association for Cancer Research}, year={1998}, volume={4 5}, pages={ 1337-43 } }
We tested the activity of dolastatin 10 (a natural product derived from the shell-less marine mollusk, Dolabella auricularia, a sea hare) and its structural modification, auristatin PE, alone and in combination with bryostatin 1 (a protein kinase C activator derived from the marine bryozoan Bugula neritina) on a human B-cell chronic lymphocytic leukemia cell line (WSU-CLL) and in a severe combined immune deficient (SCID) mouse xenograft model bearing this cell line. WSU-CLL cells were cultured… CONTINUE READING
45 Citations
Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog.
- Biology, Medicine
- Blood
- 2002
- 53
- PDF
Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug.
- Medicine
- Expert opinion on investigational drugs
- 1999
- 27
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
- Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 2000
- 119
Marine natural products: Bryostatins in preclinical and clinical studies
- Biology, Medicine
- Pharmaceutical biology
- 2014
- 58
- Highly Influenced
Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells.
- Biology, Medicine
- Cancer letters
- 2001
- 75
Preclinical and clinical studies on bryostatins, a class of marine-derived protein kinase C modulators: A mini-review.
- Biology, Medicine
- Current topics in medicinal chemistry
- 2020
- 6
Progress in the development and acquisition of anticancer agents from marine sources.
- Biology, Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2003
- 131
References
SHOWING 1-10 OF 26 REFERENCES
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.
- Biology, Medicine
- Leukemia research
- 1995
- 53
Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
- Biology, Medicine
- Leukemia research
- 1993
- 35
Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
- Medicine
- Cancer research
- 1994
- 54
Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.
- Medicine
- Cancer research
- 1992
- 149
Discovery of Solid Tumor Active Agents Using a Soft-Agar-Colony-Formation Disk-Diffusion-Assay
- Medicine
- 1992
- 49
Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
- Biology, Medicine
- Biochemical pharmacology
- 1990
- 235
Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.
- Chemistry, Medicine
- Blood
- 1988
- 120
- PDF
Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
- Medicine
- Leukemia
- 1996
- 45
Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
- Biology, Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 1996
- 53
- PDF
Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
- Biology, Medicine
- The Journal of experimental medicine
- 1992
- 363
- PDF